René Bernards
Patrimonio netto: 156 250 $ in data 31/05/2026
Patrimonio netto: 156 250 $ in data 31/05/2026
René Bernards was the founder of Agendia, Inc. (founded in 2003, Chief Scientific Officer since 2010) and Agendia NV (founded in 2003, Chief Scientific Officer from 2009 to 2010).
Dr. Bernards is currently a Director at the American Association for Cancer Research (since 2018), a Professor-Molecular Carcinogenesis at the University of Utrecht, a Member of The Royal Netherlands Academy of Arts & Sciences, the Head of the Molecular Carcinogenesis Division at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis, a Member of the National Academy of Sciences, a Member of the American Academy of Arts & Sciences, and an Operational Partner at Gilde Healthcare Partners, Inc. Formerly, Independent Director at Lixte Biotechnology Holdings, Inc. from 2022 to 2025.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2025 | 25.000 ( 0,2% ) | 156 250 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Fondatore | 01/01/2003 |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art | Corporate Officer/Principal | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Direttore/Membro del Consiglio | 01/01/2018 |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Investitore di Private Equity | - |
| Società | Posizione | Fine |
|---|---|---|
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/09/2025 |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 08/01/2020 |
| ░░░░░░░ ░░ | ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art | Commercial Services |
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. BiotechnologyHealth Technology Develops diagnostics, medication and treatments for various forms of cancer | Health Technology |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale